Dataset Information


BRG1 Loss Predisposes Lung Cancers to Replicative Stress and ATR Dependency.

ABSTRACT: Inactivation of SMARCA4/BRG1, the core ATPase subunit of mammalian SWI/SNF complexes, occurs at very high frequencies in non-small cell lung cancers (NSCLC). There are no targeted therapies for this subset of lung cancers, nor is it known how mutations in BRG1 contribute to lung cancer progression. Using a combination of gain- and loss-of-function approaches, we demonstrate that deletion of BRG1 in lung cancer leads to activation of replication stress responses. Single-molecule assessment of replication fork dynamics in BRG1-deficient cells revealed increased origin firing mediated by the prelicensing protein, CDC6. Quantitative mass spectrometry and coimmunoprecipitation assays showed that BRG1-containing SWI/SNF complexes interact with RPA complexes. Finally, BRG1-deficient lung cancers were sensitive to pharmacologic inhibition of ATR. These findings provide novel mechanistic insight into BRG1-mutant lung cancers and suggest that their dependency on ATR can be leveraged therapeutically and potentially expanded to BRG1-mutant cancers in other tissues. SIGNIFICANCE: These findings indicate that inhibition of ATR is a promising therapy for the 10% of non-small cell lung cancer patients harboring mutations in SMARCA4/BRG1. GRAPHICAL ABSTRACT: http://cancerres.aacrjournals.org/content/canres/80/18/3841/F1.large.jpg.

PROVIDER: S-EPMC7501156 | BioStudies |

REPOSITORIES: biostudies

Similar Datasets

2014-01-01 | S-EPMC3939885 | BioStudies
| S-EPMC4359251 | BioStudies
| S-EPMC6362083 | BioStudies
| S-EPMC6172278 | BioStudies
| S-EPMC4233181 | BioStudies
| S-EPMC2459551 | BioStudies
| S-EPMC2820190 | BioStudies
| S-EPMC7520014 | BioStudies
| S-EPMC7718321 | BioStudies
2020-07-08 | MSV000085701 | MassIVE